Article Information
History
- July 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rachel L Byrne1,
- Grant A Kay1,
- Konstantina Kontogianni1,
- Lottie Brown1,
- Andrea M Collins1,2,3,
- Luis E. Cuevas1,
- Daniela M Ferreira1,
- Alice J Fraser1,
- Gala Garrod1,
- Helen Hill1,2,3,
- Stefanie Menzies1,
- Elena Mitsi1,
- Sophie I Owen1,
- Christopher T Williams1,
- Angela Hyder-Wright1,2,3,
- Emily R Adams1,* and
- Ana I Cubas-Atienzar1
- 1Liverpool School of Tropical Medicine, UK
- 2National Institute for Health Research, UK
- 3Liverpool University Hospitals NHS Foundation Trust, UK
- ↵*Corresponding author: Dr Emily Adams, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, phone +44 151 705 3196, email emily.adams{at}lstmed.ac.uk
Posted July 11, 2020.
Saliva offers a sensitive, specific and non-invasive alternative to upper respiratory swabs for SARS-CoV-2 diagnosis
